135 related articles for article (PubMed ID: 11950714)
1. Tissue plasminogen activator, fibrin D-dimer, and insulin resistance in the relatives of patients with premature coronary artery disease.
Mills JD; Mansfield MW; Grant PJ
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):704-9. PubMed ID: 11950714
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic risk factor clustering and insulin resistance in healthy male relatives of men with intermittent claudication.
Parry DJ; Grant PJ; Scott DJ
Br J Surg; 2006 Mar; 93(3):315-24. PubMed ID: 16498597
[TBL] [Abstract][Full Text] [Related]
3. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
[TBL] [Abstract][Full Text] [Related]
4. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
[TBL] [Abstract][Full Text] [Related]
5. Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.
May M; Lawlor DA; Patel R; Rumley A; Lowe G; Ebrahim S
Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):638-45. PubMed ID: 17925622
[TBL] [Abstract][Full Text] [Related]
6. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
[TBL] [Abstract][Full Text] [Related]
7. Do plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional angina?
Itakura H; Sobel BE; Boothroyd D; Leung LL; Iribarren C; Go AS; Fortmann SP; Quertermous T; Hlatky MA;
Am Heart J; 2007 Dec; 154(6):1059-64. PubMed ID: 18035075
[TBL] [Abstract][Full Text] [Related]
8. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Sobel BE; Hardison RM; Genuth S; Brooks MM; McBane RD; Schneider DJ; Pratley RE; Huber K; Wolk R; Krishnaswami A; Frye RL;
Circulation; 2011 Aug; 124(6):695-703. PubMed ID: 21768545
[TBL] [Abstract][Full Text] [Related]
9. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study.
Lowe GD; Yarnell JW; Sweetnam PM; Rumley A; Thomas HF; Elwood PC
Thromb Haemost; 1998 Jan; 79(1):129-33. PubMed ID: 9459337
[TBL] [Abstract][Full Text] [Related]
10. Tissue plasminogen activator as a novel diagnostic aid in acute pulmonary embolism.
Flores J; García-Avello A; Alonso E; Ruíz A; Navarrete O; Alvarez C; Lozano C; Arribas I
Vasa; 2014 Nov; 43(6):450-8. PubMed ID: 25339163
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.
Segarra A; Chacón P; Martinez-Eyarre C; Argelaguer X; Vila J; Ruiz P; Fort J; Bartolomé J; Camps J; Moliner E; Pelegrí A; Marco F; Olmos A; Piera L
J Am Soc Nephrol; 2001 Jun; 12(6):1255-1263. PubMed ID: 11373350
[TBL] [Abstract][Full Text] [Related]
12. Increased plasminogen activator inhibitor antigen levels in diabetic patients with stable angina.
Daví G; Violi F; Catalano I; Giammarresi C; Putignano E; Nicolosi G; Barbagallo M; Notarbartolo A
Blood Coagul Fibrinolysis; 1991 Feb; 2(1):41-5. PubMed ID: 1772997
[TBL] [Abstract][Full Text] [Related]
13. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
DeSouza CA; Jones PP; Seals DR
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):362-8. PubMed ID: 9514404
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE
Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149
[TBL] [Abstract][Full Text] [Related]
15. Can the tandem measurement of age adjusted D-dimer and tissue plasminagen activator improve the clinical utility of a conventional D-dimer in the pulmonary embolism diagnosis?
Flores J; García-Avello A; Ruíz A; Alonso E; Álvarez C; Navarrete O; Arribas I
Int Angiol; 2016 Feb; 35(1):62-70. PubMed ID: 25719400
[TBL] [Abstract][Full Text] [Related]
16. Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease.
Mills J; Mansfield M; Grant P
Eur Heart J; 2002 Aug; 23(16):1276-81. PubMed ID: 12175664
[TBL] [Abstract][Full Text] [Related]
17. Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population.
Rudnicka AR; Rumley A; Lowe GD; Strachan DP
Circulation; 2007 Feb; 115(8):996-1003. PubMed ID: 17296859
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in the relation between fibrinogen, tissue-type plasminogen activator antigen and markers of insulin resistance: effects of smoking. D.E.S.I.R. Study Group. Data from an Epidemiological Study on Insulin Resistance Syndrome.
Mennen LI; Balkau B; Charles MA; D'Hour A; le Mauff JM
Thromb Haemost; 1999 Sep; 82(3):1106-11. PubMed ID: 10494772
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
20. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
